Address
Pappas Ventures
Research Triangle Park
PO Box 110287
NC 27709
United States
Website
Industry
VCID: 3260
Profile
Corporate information
Also known as
Pappas Capital
Registration country
Also known as
Pappas Capital
Registration country
Investment activity status
Active investor
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Horizon Quantum Computing Pte Ltd Developer of a new generation of programming tools to simplify and expedite the process of developing software for quantum computers. |
Singapore | 31 Mar 2023 | Series A Initial investment. Round participant. Active |
|
|
Lumena Pharmaceuticals Inc |
United States | 8 May 2013 | Series A Active |
|
|
IlluminOss Medical Inc A privately held medical device company dedicated to the development of minimally invasive orthopedic systems. |
United States | 1 Sep 2012 | Series C Active |
|
|
CardioDx Inc |
United States | 1 Aug 2012 11 May 2011 17 May 2010 |
Series F Initial investment. Round participant. Active |
|
|
|
CoLucid Pharmaceuticals Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. |
United States | 1 Aug 2011 1 Jan 2006 1 Jan 2008 |
N/A |
|
|
|
Chimerix Inc |
United States | 1 Feb 2011 | Series F |
|
|
|
TyRx Inc |
United States | 1 Dec 2010 1 Feb 2008 |
N/A |
|
|
|
LipoScience Inc Diagnostic company developing clinical applications of nuclear magnetic resonance (NMR) spectroscopy. |
1 Aug 2003 1 Aug 2006 |
Series F Active |
||
|
|
BioSyntech A medical device company |
Canada | N/A |
||
|
|
Marina Biotech |
United States | N/A |
||
|
|
Plexigen Diagnostic company focusing on instrumentation and service for a wide array of clinical testing. |
United States | N/A |
||
|
|
Syntonix Pharmaceuticals Inc A needle-free drug delivery company utilizing the FcRn receptor to transport macromolecules across epithelial barriers in the central airway and into |
United States | N/A |
||
|
|
Aclara Biosciences Inc Develops and distributes assay solutions for drug discovery and development |
United States | N/A Active |
||
|
|
BrainCells Inc A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. |
United States | N/A |